StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.96+0.00 (0.00%)

Close on Nov 16, 2026Market cap $35.53MP/E –Yield –

How the market prices Alterity Therapeutics

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Alterity Therapeutics trades at 69.7× its earnings, against a median of 2.0× since 2016 — dearer than 98% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 2.0×, today 69.7×

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by A$37.32M. That is 259.9% of the A$14.36M it would cost to buy the business outright.

Cash and short-term investmentsA$37.32M
Free cash flow, trailing twelve months-A$22.52M

Leverage and liquidity

Current ratio14.52vs 5.69
Quick ratio14.26vs 5.16

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

3.05
DistressGrey zoneSafe

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Free cash flow yield-43.6%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 16, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

32
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

ATHES&P 500
PeriodATHES&P 500DifferenceATHE per yearS&P 500 per year
1 month-25.2%-3.1%−22.1 pts
3 months-59.1%-4.5%−54.6 pts
Year to date-36.4%+9.4%−45.7 pts
1 year-49.0%+11.3%−60.3 pts
3 years-16.6%+70.4%−87.0 pts-5.9%+19.4%
5 years-82.7%+68.6%−151.2 pts-29.6%+11.0%
10 years-93.3%+297.7%−391.0 pts-23.7%+14.8%

How much it moves

Beta against the S&P 5000.95vs 1.38
Volatility, 1 year69.2%vs 129.0%
Volume against its 90-day average0.20vs 0.20

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ATHE shares were sold short on Oct 30, 2026, down 36.1% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 55.2% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Days of volume to buy it back1.00vs 2.08

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202624,614-36.1%25,3531.0
Oct 15, 202638,516+47.5%32,8211.2
Sep 30, 202626,107+1.7%12,0372.2
Sep 15, 202625,660-18.4%19,9461.3
Aug 31, 202631,452+27.0%22,8831.4
Aug 14, 202624,763+17.4%7,6833.2
Jul 31, 202621,094-44.5%10,7882.0
Jul 15, 202638,037-2.4%17,9832.1
Jun 30, 202638,980-27.8%33,1811.2
Jun 15, 202654,009+486.0%148,3191.0
May 29, 20269,216+14.5%21,8171.0
May 15, 20268,051-42.1%28,2121.0

Every measure, in full

42 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
A$51.67M
A$13.19M
Enterprise Value
A$14.36M
A$1.54M

Share statisticsIndustry

Shares Change (YoY)
64.5%
28.6%
Float
200M
317M
Shares Held by Insiders
7.82%
1.94%
Shares Held by Institutions
0.18%
–

Short sellingIndustry

Short Interest
24,614
–
Short Interest Change
-36.1%
-27.5%
Days to Cover
1.00
2.08

Stock price statisticsIndustry

Price Change (1 Week)
-19.3%
-19.3%
Price Change (1 Month)
-25.2%
-19.5%
Price Change (3 Months)
-57.0%
-57.0%
Price Change (6 Months)
-54.8%
-54.8%
Price Change (YTD)
-36.4%
-36.4%
Price Change (1 Year)
-46.9%
-46.9%
Price Change (3 Years)
-17.6%
–
Price Change (5 Years)
-82.3%
–
Price Change (10 Years)
-92.8%
–
Average Volume (10 Days)
446,272
–
Average Volume (20 Days)
233,537
–
Average Volume (90 Days)
66,242
–
Relative Volume
0.20
0.20
Relative Strength Index (14)
31.9
31.9
Volatility (1 Year)
69.2%
129.0%
Beta (5 Years)
0.95
1.38

Financial positionIndustry

Current Ratio
14.52
5.69
Quick Ratio
14.26
5.16

EfficiencyIndustry

Employee Count
11
–
WACC
9.85%
12.0%

Income statement (TTM)Industry

Pretax Income
-A$23.29M
-A$22.45M

Balance sheetIndustry

Net Cash (Debt)
A$37.32M
A$37.32M
Net Cash Per Share
0.17 AUD
0.04 AUD
Working Capital
A$42.67M
A$42.67M

Cash flow (TTM)Industry

Operating Cash Flow
-A$22.52M
-A$13.28M
Capital Expenditures
A$0
–
Free Cash Flow
-A$22.52M
–
FCF Per Share
-0.10 AUD
–

Dividends and yieldsIndustry

FCF Yield
-43.6%
–

Taxes and interestIndustry

Income Tax
A$113.50K
–

Scores and fair valueIndustry

Altman Z-Score
3.05
-1.78

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?